Sept. 14, 2021 Price forecast | 2 weeks: -1.73% | 1 month: -4.11% | 3 months: -3.82%


AGL stock forecast

Our latest prediction for Agilon Health Inc's stock price was made on the Sept. 14, 2021 when the stock price was at 31.14$.

In the short term (2weeks), AGL's stock price should underperform the market by -1.73%. During that period the price should oscillate between -9.87% and +9.71%.

In the medium term (3months), AGL's stock price should underperform the market by -3.82%. During that period the price should oscillate between -32.94% and +27.62%.

Create a solid portfolio with AGL

Add AGL to your portfolio and optimize it!


About Agilon Health Inc

agilon health is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. agilon health enables physicians to create their own Medicare-centric globally capitated line of business. The agilon Total Care Model is powered by its purpose-built platform and enabled through a growing national network of like-minded physician partners. With agilon, physicians are freed from the constraints of the transactional fee-for-service reimbursement model and are able to practice team-based, coordinated care to serve the individual needs of their senior patients and to transition to a sustainable and predictable, long-term business model. The rapidly growing appeal of the agilon platform, partnership model and network of leading community-based physicians has allowed the company to expand to 17 local communities with 16 anchor physician groups, as well as a network of physicians across Hawaii, in fewer than five years.

At the moment the company generates 1546M USD in revenues.

On its last earning announcement, the company reported a loss of -0.90$ per share.

The book value per share is 2.94$

Agilon Health Inc website


Three months stock forecastSept. 14, 2021


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
1546M 5.30% -360M -23.30% -350M -0.90 - - 391M 2.94 -98M -6M -104M